Drinking Coffee May Cut Risk Of Chronic Liver Disease

Drinking either caffeinated coffee (ground or instant coffee) or decaffeinated coffee can reduce risk of chronic liver disease and related liver diseases. A study published in the journal BMC Public Health Open by researchers at the Universities of Southampton and Edinburgh in the UK. 

The benefit of drinking 3-4 cups of coffee a day is the highest. The researchers studied data from 495,585 participants in the UK Biobank who were known to drink coffee and were followed for an average of 10.7 years to monitor them for the development of chronic liver disease and associated liver disease. 

Cistanche Coffee for Improving Liver Function

Of the participants, 78% (384 818) drank caffeinated or decaffeinated coffee, while 22% (109 767) did not drink any coffee. During the study period, a total of 3600 cases of chronic liver disease occurred, including 301 deaths. In addition, there were 5,439 cases of hepatic steatosis (ie fatty liver) and 184 cases of hepatocellular carcinoma (a type of liver cancer).

Statistics show that coffee drinkers have a reduced risk of chronic liver disease compared with non-coffee drinkers

21%, the risk of hepatic steatosis was reduced by 20%, and the risk of death was reduced by 49%.

Coffee powder contains large amounts of cafestol and cafestol, which have been shown to be beneficial for chronic liver disease in animals.

Instant coffee, which is lower in cafestol and cafestol, also reduces the risk of chronic liver disease to a lesser extent than ground coffee. But this finding may suggest that other ingredients, or potentially multiple combinations of ingredients, are also beneficial.

The researchers pointed out that this study means that coffee may provide a potential preventive treatment for chronic liver disease. This is especially important in countries with lower incomes and poor access to healthcare, where the burden of chronic liver disease is the highest.

Support:

wallence.suen@wecistanche.com   0015292862950